NCT02787733

Brief Summary

Rationale: Numerous studies have shown the positive effect of a healthy diet and regular moderate exercise. Although, exercise has also been correlated with an increase in reactive oxygen species (ROS) production and a higher incidence of injury. ROS production seems to induce muscle damage, which reduces muscle performance and induces fatigue. Increasing muscle recovery could be an effective way to increase exercise performance. Several food ingredients have been of growing interest due to their specific functioning on the human body. Citrus flavonoids are abundantly available in citrus fruits. Prior studies show a positive effect of citrus flavonoids on endothelial function, by promoting vasodilation. In addition it has a positive effect on the nitric oxide (NO) synthesis, a known compound in regulating endothelial response. This capacity of citrus flavonoids could be useful in stimulating performance and recovery after exercise. Additionally, the ability of scavenging ROS could reduce muscle damage caused by exercise induced oxidative damage. Objective: Determine the 4-week effect of daily citrus flavonoid supplementation on exercise recovery and performance. Study design: Randomized, double-blind, placebo-controlled study with parallel design, in which 40 subjects engage in three exercise sessions. The sessions will be subdivided into a pre-test and test 1 and 2. Between test 1 and 2, participants receive daily for 4 weeks citrus flavonoid supplement or a placebo. Each day, subjects should consume 2 capsules each morning, containing in total 500 mg of citrus flavonoids or 500 mg placebo. Study population: The subjects will be healthy normal weight trained males, with an age of 18 - 25. Additionally, subjects are non-smokers and free of a medication. Intervention: Participants will be randomly placed in either the citrus flavonoid or placebo group. Participants will be instructed to ingest 2 capsules each morning for 4 consecutive weeks. Each capsule equals to 250 mg of citrus flavonoids or cellulose in case of the placebo treatment. Main study parameters/endpoints: The main study parameter is the average amount of work load produced during the 10-minute time trail test. In addition, oxygen per minute will be determined as well as the heart rate. Finally, for each test, the subjective rating of perceived exertion (RPE) will be determined during the pre-test and test 1 and 2 by using a Borg scale.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2014

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2014

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

May 24, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 1, 2016

Completed
Last Updated

June 3, 2016

Status Verified

June 1, 2016

Enrollment Period

5 months

First QC Date

May 24, 2016

Last Update Submit

June 1, 2016

Conditions

Keywords

performancerecovery

Outcome Measures

Primary Outcomes (1)

  • Average force output (Watts) in endurance cycling exercise after pre-exhaustive exercise

    Average force output is measured through a cycle ergometer

    4 week

Secondary Outcomes (1)

  • Maximum oxygen uptake (ml/kg/min) in endurance cycling exercise after pre-exhaustive exercise

    4 weeks

Study Arms (2)

Citrus flavonoid

EXPERIMENTAL

Citrus peel extract containing \>90% flavonoids

Dietary Supplement: Citrus flavonoid

Placebo

PLACEBO COMPARATOR

Identical looking placebo

Dietary Supplement: Placebo

Interventions

Citrus flavonoidDIETARY_SUPPLEMENT

Daily dose of 500mg divided over two capsules

Citrus flavonoid
PlaceboDIETARY_SUPPLEMENT

Daily dose of 500mg divided over two capsules

Placebo

Eligibility Criteria

Age18 Years - 25 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Trained participants, defined as engaging at least 3 times a week in moderate to high physical activity for a minimum of 30 minutes
  • Non-smoking, defined as no smoking for the last 6 months
  • Participants are capable and willing to give written informed consent voluntarily after receiving detailed information from the researchers

You may not qualify if:

  • Cardiovascular complications
  • Extreme BMI (i.e. lower than 18 or higher than 30)
  • Use of medication
  • Use of antioxidants, minerals and vitamin supplements available in pharmacies, drugstores, food markets or in alternative medicine
  • Abuse of products; alcohol (\> 20 alcoholic consumptions per week) and drugs
  • Administration of investigational drugs or participation in any scientific intervention study which may interfere with this study (to be decided by the principle investigator) in the 180 days prior to the study
  • Failure to comply prohibited intake of hesperidin containing food products during study period. A list with forbidden food products will be provided to participant
  • History of any side effects towards the intake of flavonoids or citrus fruits

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

InnoSportLab Papendal

Arnhem, Gelderland, 6816VD, Netherlands

Location

Study Officials

  • Bouke Salden, Drs.

    BioActor

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
BioActorBV

Study Record Dates

First Submitted

May 24, 2016

First Posted

June 1, 2016

Study Start

July 1, 2014

Primary Completion

December 1, 2014

Study Completion

December 1, 2014

Last Updated

June 3, 2016

Record last verified: 2016-06

Locations